Methods and compounds to modulate inherited genetic diseases

CO20260009882A2Pending Publication Date: 2026-07-21DESIGN THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
DESIGN THERAPEUTICS INC
Filing Date
2026-07-02
Publication Date
2026-07-21
Patent Text Reader

Abstract

This disclosure relates to compounds, compositions, and methods of transcription modulator molecules for the treatment of DM1 and FECD.
Need to check novelty before this filing date? Find Prior Art